Vanguard Group Portfolio holdings
Vanguard Group is an investment manager owned by the funds it manages, and so by its own customers. John Bogle founded it in 1975 and is credited with creating the first index fund available to individual investors. After Wellington Management fired Bogle in 1974, he started a new fund division there and named it Vanguard after HMS Vanguard, Horatio Nelson's flagship. Bogle set up its first index fund in 1976, the fund that became the Vanguard 500 Index Fund, and the firm added a bond index fund in 1986. It began offering ETFs in 2001 as exchange-traded shares of its index funds, and it also serves employers' retirement plans and independent financial advisers. Salim Ramji, who came from BlackRock, was named chief executive in 2024 as the first outsider to lead the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$8.03B |
| 2 |
Microsoft
MSFT
|
+$8B |
| 3 |
Apple
AAPL
|
+$7.21B |
| 4 |
TotalEnergies
TTE
|
+$5.18B |
| 5 |
Meta Platforms (Facebook)
META
|
+$4.85B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kellanova
K
|
+$2.74B |
| 2 |
DuPont de Nemours
DD
|
+$2.65B |
| 3 |
Mr. Cooper
COOP
|
+$1.41B |
| 4 |
Interpublic Group of Companies
IPG
|
+$1.24B |
| 5 |
Amazon
AMZN
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Financials | 13.5% |
| 3 | Consumer Discretionary | 9.9% |
| 4 | Healthcare | 9.82% |
| 5 | Communication Services | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3401
Catalyst Bancorp
CLST
| $3.4M | ﹤0.01% |
215,633
-4,206
| -2% | -$60.7K |
2021 Q4
16 quarters
|
|
3402
Safe Bulkers
SB
$944M
| $3.39M | ﹤0.01% |
702,661
-62,932
| -8% | -$299K |
2017 Q2
34 quarters
|
|
3403
Northern Technologies International Corp
NTIC
$72.4M
| $3.34M | ﹤0.01% |
426,751
+1,900
| +0.4% | +$14.6K |
2013 Q2
50 quarters
|
|
3404
FitLife Brands
FTLF
$79.6M
| $3.34M | ﹤0.01% |
205,060
+4,515
| +2% | +$83K |
2024 Q2
6 quarters
|
|
3405
vTv Therapeutics
VTVT
$79M
| $3.34M | ﹤0.01% |
83,400
+36,410
| +77% | +$1.01M |
2015 Q3
41 quarters
|
|
3406
Blink Charging
BLNK
$61M
| $3.3M | ﹤0.01% |
4,945,979
+237,320
| +5% | +$343K |
2018 Q2
30 quarters
|
|
3407
Real REMAX Group Inc. Common Stock
REAX
$406M
| $3.26M | ﹤0.01% |
89,406
+19,111
| +27% | +$739K |
2024 Q2
6 quarters
|
|
3408
Legend Biotech
LEGN
$3.39B
| $3.25M | ﹤0.01% |
149,619
+12,022
| +9% | +$344K |
2021 Q4
16 quarters
|
|
3409
Kestrel Group
KG
$29.4M
| $3.25M | ﹤0.01% |
317,452
+7,515
| +2% | +$135K |
2013 Q2
50 quarters
|
|
3410
Actuate Therapeutics
ACTU
$6.85M
| $3.24M | ﹤0.01% |
529,111
+213,101
| +67% | +$1.46M |
2024 Q4
4 quarters
|
|
3411
Patriot National Bancorp
PNBK
$109M
| $3.22M | ﹤0.01% |
1,766,896
+480,835
| +37% | +$663K |
2021 Q2
18 quarters
|
|
3412
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.3B
| $3.21M | ﹤0.01% |
5,320
+383
| +8% | +$229K |
2023 Q1
11 quarters
|
|
3413
DELISTED
NextNRG Inc
NXXT
| $3.2M | ﹤0.01% |
22,036
+11,543
| +110% | +$1.99M |
2025 Q2
2 quarters
|
|
3414
Annovis Bio
ANVS
$39.8M
| $3.19M | ﹤0.01% |
923,201
+185,198
| +25% | +$557K |
2021 Q1
19 quarters
|
|
3415
DELISTED
AstroNova
ALOT
| $3.16M | ﹤0.01% |
365,866
+13,735
| +4% | +$120K |
2013 Q2
50 quarters
|
|
3416
AMREP Corp
AXR
$111M
| $3.16M | ﹤0.01% |
168,177
-4,734
| -3% | -$102K |
2013 Q2
50 quarters
|
|
3417
Shoulder Innovations Inc
SI
$433M
| $3.15M | ﹤0.01% |
220,430
+74,162
| +51% | +$1.01M |
2025 Q3
1 quarter
|
|
3418
Castellum
CTM
$41.7M
| $3.14M | ﹤0.01% |
3,473,227
+2,195,312
| +172% | +$2.34M |
2023 Q1
11 quarters
|
|
3419
iShares Russell 2000 Growth ETF
IWO
$13.9B
| $3.14M | ﹤0.01% |
9,708
+362
| +4% | +$118K |
2023 Q2
10 quarters
|
|
3420
Tenax Therapeutics
TENX
$73.8M
| $3.12M | ﹤0.01% |
255,664
+93,864
| +58% | +$816K |
2024 Q4
4 quarters
|
|
3421
Critical Metals Corp
CRML
$948M
| $3.1M | ﹤0.01% |
446,592
+155,488
| +53% | +$1.7M |
2024 Q2
6 quarters
|
|
3422
Red Robin
RRGB
$167M
| $3.1M | ﹤0.01% |
765,185
+12,376
| +2% | +$62.1K |
2013 Q2
50 quarters
|
|
3423
PetMed Express
PETS
$20.9M
| $3.08M | ﹤0.01% |
963,759
-293
| -0% | -$735 |
2013 Q2
50 quarters
|
|
3424
Gaia
GAIA
$31.8M
| $3.07M | ﹤0.01% |
847,010
+11,071
| +1% | +$50.6K |
2013 Q2
50 quarters
|
|
3425
HireQuest
HQI
$197M
| $3.07M | ﹤0.01% |
291,899
-1,114
| -0.4% | -$9.8K |
2019 Q2
26 quarters
|
|
Similar funds
Vanguard Group's Q4 2025 Portfolio in Review
As of Q4 2025, Vanguard Group held 4,426 positions worth $6.9T, up 3.3% from $6.68T the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q4 2025: portfolio turnover was 4.1%. Vanguard Group opened 82 new positions and exited 98, leaving the 4,426-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- Vanguard Group's largest Q4 2025 buy was TotalEnergies: 81,863,403 shares worth $5.34B.
- Vanguard Group added most to NVIDIA in Q4 2025, an estimated $8.03B increase.
- Vanguard Group's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $2.65B.
- Vanguard Group fully exited Kellanova in Q4 2025, selling an estimated $2.74B.
- Vanguard Group's ten largest holdings make up 31% of its $6.9T portfolio in Q4 2025.
- Vanguard Group opened 82 new positions and closed 98 in Q4 2025.
- Vanguard Group's portfolio value rose 3.3% quarter-over-quarter to $6.9T.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.